Manning & Napier Group, LLC Astrazeneca PLC Transaction History
Manning & Napier Group, LLC
- $8.76 Billion
- Q1 2024
A detailed history of Manning & Napier Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Manning & Napier Group, LLC holds 2,811,069 shares of AZN stock, worth $219 Million. This represents 2.17% of its overall portfolio holdings.
Number of Shares
2,811,069
Previous 2,779,212
1.15%
Holding current value
$219 Million
Previous $187 Million
1.75%
% of portfolio
2.17%
Previous 2.23%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,246Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.78 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...